BioSpace News Archive

GBP510, a recombinant vaccine against COVID-19, adjuvanted with AS03, has shown to be highly immunogenic and well tolerated in healthy adults.

Artelo Biosciences, Inc. announced new research published in the peer-reviewed journal Pharmaceuticals.

Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, reported financial results for the third quarter ended September 30, 2023.

Medicenna Therapeutics Corp. announced that a poster presentation and an oral summary highlighting long-term follow up from the Phase 2b clinical trial of bizaxofusp, the Company’s first-in-class IL-4R targeted therapy, will be presented at the Society for Neuro-Oncology 2023 Annual Meeting, taking place from November 15-19, 2023, in Vancouver, Canada.

Cadrenal Therapeutics, Inc. provided a corporate update in connection with the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.

Gilead Sciences / Dr. Shringar Rao’s inquisitive nature and dedication to addressing health inequities drive her eagerness to help advance innovative scientific breakthroughs.

Melinta Therapeutics LLC and Venatorx Pharmaceuticals, Inc., announced that they have entered into a License Agreement to facilitate a strategic partnership in the U.S. to commercialize cefepime-taniborbactam, a beta-lactam / beta-lactamase inhibitor combination antibiotic being developed for the treatment of complicated urinary tract infections and hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in adults.

The Life Science business of Merck KGaA, Darmstadt, Germany was named a World Sustainability Awards 2023 winner at the World Sustainability Awards 2023.

Pharvaris announced the presentation of two ePosters at the American College of Allergy, Asthma & Immunology 2023 Annual Scientific Meeting, being held from November 9-13, 2023 in Anaheim, CA.

Intrommune Therapeutics, Inc. will present top-line results of the Phase 1 OMEGA clinical trial during a late-breaking oral presentation at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting in Anaheim, California.